Literature DB >> 26610393

Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain.

Theodoros Papathanasiou1, Rasmus Vestergaard Juul1, Anne-Marie Heegaard1, Mads Kreilgaard1, Trine Meldgaard Lund1.   

Abstract

Despite much evidence that combination of morphine and gabapentin can be beneficial for managing postoperative pain, the nature of the pharmacological interaction of the two drugs remains unclear. The aim of this study was to assess the interaction of morphine and gabapentin in range of different dose combinations and investigate whether co-administration leads to synergistic effects in a preclinical model of postoperative pain. The pharmacodynamic effects of morphine (1, 3 and 7mg/kg), gabapentin (10, 30 and 100mg/kg) or their combination (9 combinations in total) were evaluated in the rat plantar incision model using an electronic von Frey device. The percentage of maximum possible effect (%MPE) and the area under the response curve (AUC) were used for evaluation of the antihyperalgesic effects of the drugs. Identification of synergistic interactions was based on Loewe additivity response surface analyses. The combination of morphine and gabapentin resulted in synergistic antihyperalgesic effects in a preclinical model of postoperative pain. The synergistic interactions were found to be dose dependent and the increase in observed response compared to the theoretical additive response ranged between 26 and 58% for the synergistic doses. The finding of dose-dependent synergistic effects highlights that choosing the right dose-dose combination is of importance in postoperative pain therapy. Our results indicate benefit of high doses of gabapentin as adjuvant to morphine. If these findings translate to humans, they might have important implications for the treatment of pain in postoperative patients.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug–drug interactions; Gabapentin; Loewe; Morphine; Postoperative pain; Synergy; Von Frey

Mesh:

Substances:

Year:  2015        PMID: 26610393     DOI: 10.1016/j.ejps.2015.11.015

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  10 in total

1.  Optimizing Dose-Finding Studies for Drug Combinations Based on Exposure-Response Models.

Authors:  Theodoros Papathanasiou; Anders Strathe; Rune Viig Overgaard; Trine Meldgaard Lund; Andrew C Hooker
Journal:  AAPS J       Date:  2019-07-29       Impact factor: 4.009

2.  Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations.

Authors:  Theodoros Papathanasiou; Anders Strathe; Andrew C Hooker; Trine Meldgaard Lund; Rune Viig Overgaard
Journal:  AAPS J       Date:  2018-04-23       Impact factor: 4.009

3.  Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat.

Authors:  Theodoros Papathanasiou; Rasmus Vestergaard Juul; Charlotte Gabel-Jensen; Mads Kreilgaard; Trine Meldgaard Lund
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.200

4.  Complex encephalopathy arising from the combination of opioids and gabapentin.

Authors:  Harpreet Singh; Richa Handa; Vivek Kak; Alicja Wasilewski
Journal:  BMJ Case Rep       Date:  2019-04-20

5.  Quantification of the Pharmacodynamic Interaction of Morphine and Gabapentin Using a Response Surface Approach.

Authors:  Theodoros Papathanasiou; Rasmus Vestergaard Juul; Charlotte Gabel-Jensen; Mads Kreilgaard; Anne-Marie Heegaard; Trine Meldgaard Lund
Journal:  AAPS J       Date:  2017-08-29       Impact factor: 4.009

6.  Efficacy of Intrathecal Morphine in a Model of Surgical Pain in Rats.

Authors:  Aurelie Thomas; Amy Miller; Johnny Roughan; Aneesa Malik; Katherine Haylor; Charlotte Sandersen; Paul Flecknell; Matthew Leach
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

Review 7.  Review about gabapentin misuse, interactions, contraindications and side effects.

Authors:  Gabriel C Quintero
Journal:  J Exp Pharmacol       Date:  2017-02-09

8.  Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids.

Authors:  Payal H Desai; Olesya Taylor; Kunal J Shah; Kirk E Evoy; Alyssa M Peckham
Journal:  Ment Health Clin       Date:  2021-07-16

9.  Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice.

Authors:  Cristina D Peterson; Kelley F Kitto; Eyup Akgün; Mary M Lunzer; Maureen S Riedl; Lucy Vulchanova; George L Wilcox; Philip S Portoghese; Carolyn A Fairbanks
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

10.  Postoperative pain-from mechanisms to treatment.

Authors:  Esther M Pogatzki-Zahn; Daniel Segelcke; Stephan A Schug
Journal:  Pain Rep       Date:  2017-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.